Continuity on the Management Board of Bertrandt AG Ehningen, March 24, 2023 – Continuity on the Management Board of Bertrandt AG. Michael Lücke (Member of the Management Board – Sales) and Markus Ruf (Member of the Management Board – Finance) have been confirmed in their positions and have been appointed for a further five years.… Read More »
Aduhelm by Biogen Source: Biogen The FDA’s approval of Biogen‘s Alzheimer’s drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer’s Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug… Read More »
This week, Raley’s, a grocery chain based in California, released its first-ever Raley’s 2020 Impact Report “Imagine a grocery store with a higher purpose,” the landing page for the company’s social impact resources calls us to do. In today’s post, I explore — or chew on, if you will — Raley’s Report through the lens… Read More »
Receiving an initial antibiotic prescription for a viral acute respiratory infection — the type of infection that doesn’t respond to antibiotics — increases the likelihood that a patient or their spouse will seek care for future such infections and will receive subsequent antibiotic prescriptions, according to the findings of a study from Harvard Medical School… Read More »
The relaxation of telehealth regulations in response to the COVID-19 pandemic has triggered a wave of interest and support, with patients noting the convenience, discretion and safety of virtual care as major selling points. But another, perhaps less publicized advantage of telemedicine is the availability of specialists for patients – particularly those with chronic… Read More »